Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 13 of 13

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Next-generation ocular topical SBT-272 demonstrates optimized retina tissue exposure: building upon elamipretide for treating dry AMD

Michael DiMatteo; James Wakefield; John Ciallella; Anthony Abbruscato; David Ryan Lally

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):707.

ARVO Annual Meeting Abstract June 2024

Screen failures in clinical trials in retina

Nasiq Hasan; Kunaal Mehrotra; Carl J Danzig; David Aaron Eichenbaum; Amy Ewald; Carl Regillo; Bita Momenaei; Veeral Sheth; David Ryan Lally; Jay Chhablani

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5104.

ARVO Annual Meeting Abstract June 2023

The DAVIO trial: a phase 1, open-label, dose-escalation study of a single injection of EYP-1901 (vorolanib in Durasert ® platform) demonstrating reduced treatment burden in wet age-related macular degeneration

Ashkan Michael Abbey; Sunil S Patel; Mark Barakat; Vrinda S Hershberger; William Z Bridges; David Aaron Eichenbaum; David Lally; Philip P Storey; Monica Roy; Jay S Duker; Dario A Paggiarino

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):931.

ARVO Annual Meeting Abstract June 2023

Elamipretide-Mediated Visual Function Improvements Are Associated With Ellipsoid Zone Integrity in Patients With Geographic Atrophy

David Lally; Anthony Abbruscato; Sari Yordi; Hasan Cetin; Victoria Eileen Whitmore; Gagan Kalra; Yavuz Cakir; Conor Anthony McConville; Sunil K Srivastava; Justis P Ehlers

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2261.

ARVO Annual Meeting Abstract June 2023

Incomplete RPE and Outer Retinal Atrophy (iRORA) Development in Dry Age-Related Macular Degeneration (AMD) in Patients with Fellow-Eye Neovascular AMD

Hanna Choi; Giulia Corradetti; Sophiana Lindenberg; Ayesha Nuri Karamat; Deniz Oncel; Henry Liu; Ramya Gnanaraj; Sohaib Fasih-Ahmad; Kenneth Marion; Kirstie Baker; Shilpa Gulati; Bradley Foster; Andrew Lam; SriniVas R Sadda; David Lally

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):920.

ARVO Annual Meeting Abstract June 2023

Treatment response to avacincaptad pegol by baseline patient characteristics: A prespecified subgroup analysis of the phase 3 GATHER2 study

Carl J Danzig; Peter Kaiser; David Lally; Glenn J Jaffe; Arshad M. Khanani; Charles Clifton Wykoff; Jeffrey S Heier; Justin Tang; Liansheng Zhu; Julie Clark

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):984.

ARVO Annual Meeting Abstract June 2022

Subretinal drusenoid deposits is associated with increased risk towards the development of iRORA and cRORA

Hanna Choi; David Lally

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1051 – F0298.

ARVO Annual Meeting Abstract June 2021

Effect of subretinal fluid (SRF) resolution on visual acuity in patients with neovascular age-related macular degeneration (nAMD)

David Ryan Lally; Lauren Hill; Min Tsuboi

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):338.

ARVO Annual Meeting Abstract June 2020

Assessment of Progression of Geographic Atrophy in the FILLY Study

Allen Chiang; David Lally

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4307.

ARVO Annual Meeting Abstract June 2020

Performance of a novel deep learning algorithm for Automatic Retinal Fluid Quantification in Home OCT Images

David Lally; Judy E Kim; Michael J Elman; Oren Tomkins-Netzer; Yael Alon; Elad Bergman; Anat Loewenstein

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2571.

ARVO Annual Meeting Abstract April 2014

Evaluation of Spectral-domain Optical Coherence Tomography in Patients with Hydroxychloroquine Retinal Toxicity after Drug Cessation

David Ryan Lally; Steven Maler; Igor I Bussel; Andre J Witkin; Elias Reichel; Chirag Shah; Jeffrey Heier; Jay S Duker

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4879.

ARVO Annual Meeting Abstract April 2014

Retinal Injury from Accidental Laser Exposure: Evolution of Changes on SD-OCT and Examination

Gregory D Lee; Caroline R Baumal; David Ryan Lally; Elias Reichel; Jay S Duker

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6368.

ARVO Annual Meeting Abstract March 2012

Neovascular Events In Eyes With Central Retinal Vein Occlusion (CRVO) Undergoing Intravitreal Bevacizumab Or Ranibizumab Therapy

David R. Lally; Francis C. DeCroos; Mohammed Khuthaila; Rayan Alshareef; Allen C. Ho; Carl D. Regillo; Marc J. Spirn

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):872.

Advertisement